While price reduction cards will help relieve the burden of significant drug prices during the short-term, they don't address the systemic troubles driving up prescription charges in the U.S. Broader policy alterations could deal with the foundation leads to of climbing drug costs, for example deficiency of transparency in pricing as well as role o